Free Trial

Immunovant (IMVT) Short Interest Ratio & Short Volume

Immunovant logo
$18.32 -0.07 (-0.38%)
Closing price 04:00 PM Eastern
Extended Trading
$17.77 -0.55 (-2.97%)
As of 07:26 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Immunovant Short Interest Data

Immunovant (IMVT) has a short interest of 20.44 million shares, representing 29.79% of the float (the number of shares available for trading by the public). This marks a 2.61% increase in short interest from the previous month. The short interest ratio (days to cover) is 14.6, indicating that it would take 14.6 days of the average trading volume of 1.48 million shares to cover all short positions.

Current Short Interest
20,440,000 shares
Previous Short Interest
19,920,000 shares
Change Vs. Previous Month
+2.61%
Dollar Volume Sold Short
$327.04 million
Short Interest Ratio
14.6 Days to Cover
Last Record Date
June 30, 2025
Outstanding Shares
171,070,000 shares
Float Size
68,620,000 shares
Short Percent of Float
29.79%
Today's Trading Volume
1,214,533 shares
Average Trading Volume
1,479,903 shares
Today's Volume Vs. Average
82%
Short Selling Immunovant?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Immunovant and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

IMVT Short Interest Over Time

IMVT Days to Cover Over Time

IMVT Percentage of Float Shorted Over Time

Immunovant Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/30/202520,440,000 shares $327.04 million +2.6%29.8%14.6 $16.00
6/15/202519,920,000 shares $311.95 million -8.1%29.1%12.6 $15.66
5/31/202521,680,000 shares $322.38 million +1.3%31.6%12.5 $14.87
5/15/202521,400,000 shares $297.89 million +3.3%31.4%12.7 $13.92
4/30/202520,710,000 shares $334.47 million -0.6%30.4%11.7 $16.15
4/15/202520,830,000 shares $322.24 million +5.8%30.5%11.7 $15.47
3/31/202519,690,000 shares $336.50 million +24.6%28.9%11.6 $17.09
3/15/202515,800,000 shares $308.42 million +2.7%22.8%11 $19.52
2/28/202515,390,000 shares $317.03 million +4.1%22.2%13.3 $20.60
2/15/202514,790,000 shares $300.68 million +12.5%21.3%13.2 $20.33
1/31/202513,150,000 shares $285.88 million +2.5%19.2%11.7 $21.74
1/15/202512,830,000 shares $313.05 million +4.7%21.7%13.8 $24.40
12/31/202412,260,000 shares $303.68 million -2.9%19.7%14.6 $24.77
12/15/202412,630,000 shares $331.92 million -0.3%20.3%14.9 $26.28
11/30/202412,670,000 shares $357.29 million -2.7%20.4%15.2 $28.20
11/15/202413,020,000 shares $346.72 million -0.6%21.0%14.5 $26.63
10/31/202413,100,000 shares $383.31 million +1.3%21.1%15.6 $29.26
10/15/202412,930,000 shares $369.15 million +2.3%20.8%14.3 $28.55
9/30/202412,640,000 shares $360.37 million +1.4%20.4%13.1 $28.51
9/15/202412,460,000 shares $369.69 million +0.6%20.1%11.9 $29.67
8/31/202412,390,000 shares $382.85 million +1.3%20.0%11.9 $30.90
8/15/202412,230,000 shares $377.66 million +9.1%19.8%10.6 $30.88
7/31/202411,210,000 shares $325.87 million +10.1%18.1%9.8 $29.07
7/15/202410,180,000 shares $310.59 million +1.6%16.5%8.9 $30.51
6/30/202410,020,000 shares $264.53 million -1.1%16.0%8.8 $26.40
6/15/202410,130,000 shares $263.38 million +10.0%16.4%8.9 $26.00
5/31/20249,210,000 shares $233.84 million -0.9%15.0%7.8 $25.39
5/15/20249,290,000 shares $287.34 million +3.7%15.3%8.7 $30.93
4/30/20248,960,000 shares $245.86 million +5.3%14.8%7.9 $27.44
4/15/20248,510,000 shares $259.30 million -5.7%14.1%7.4 $30.47
3/31/20249,020,000 shares $291.44 million -3.5%14.9%7.3 $32.31
3/15/20249,350,000 shares $285.46 million +7.7%15.3%7.1 $30.53
2/29/20248,680,000 shares $307.01 million -3.7%14.3%6.1 $35.37
2/15/20249,010,000 shares $340.58 million +8.4%14.8%6 $37.80
1/31/20248,310,000 shares $302.57 million +3.4%13.7%5.5 $36.41
1/15/20248,040,000 shares $340.57 million +7.8%13.3%5.1 $42.36
12/31/20237,460,000 shares $314.29 million -2.1%12.3%4.8 $42.13
12/15/20237,620,000 shares $325.68 million +10.6%12.6%3.1 $42.74
11/30/20236,890,000 shares $269.61 million -2.4%11.4%3.1 $39.13
11/15/20237,060,000 shares $241.73 million +5.5%11.6%3.3 $34.24
Genesis 14:13-17 [HIDDEN MEANING?] (Ad)

A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthright” — a $150 trillion wealth vault that’s remained untouched for over a century. Jim Rickards believes President Trump is about to unleash it — and investors who move first could come out on top. The full story is now available.

Watch the presentation on America’s hidden birthright
10/31/20236,690,000 shares $221.10 million -0.3%14.3%3 $33.05
10/15/20236,710,000 shares $251.02 million -8.0%14.3%3.2 $37.41
9/30/20237,290,000 shares $279.86 million +42.1%15.5%3.5 $38.39
9/15/20235,130,000 shares $111.89 million +4.7%9.7%4.6 $21.81
8/31/20234,900,000 shares $111.28 million +28.6%9.3%4.3 $22.71
8/15/20233,810,000 shares $78.18 million +2.7%7.3%3.4 $20.52
7/31/20233,710,000 shares $84.70 million +3.6%7.2%3.4 $22.83
7/15/20233,580,000 shares $74.25 million -2.7%6.9%3.2 $20.74
6/30/20233,680,000 shares $69.81 million +7.6%7.1%3.5 $18.97
6/15/20233,420,000 shares $72.26 million -0.3%6.6%3.2 $21.13
5/31/20233,430,000 shares $72.06 million -20.4%6.7%3.4 $21.01
5/15/20234,310,000 shares $79.35 million -4.9%8.4%4.6 $18.41
4/30/20234,530,000 shares $73.11 million -3.6%8.8%5.2 $16.14
4/15/20234,700,000 shares $67.07 million -3.5%9.2%5.5 $14.27
3/31/20234,870,000 shares $75.53 million +21.8%9.4%5.2 $15.51
3/15/20234,000,000 shares $61.64 million +16.6%7.6%3.9 $15.41
2/28/20233,430,000 shares $59.92 million +19.9%6.6%3.2 $17.47
2/15/20232,860,000 shares $51.85 million +23.3%5.5%2.6 $18.13
1/31/20232,320,000 shares $41.23 million -4.5%4.4%2 $17.77
1/15/20232,430,000 shares $45.20 million -32.5%4.7%2.1 $18.60
12/30/20223,600,000 shares $63.90 million +27.2%7.0%3.2 $17.75
12/15/20222,830,000 shares $43.04 million +8.0%5.5%2 $15.21
11/30/20222,620,000 shares $34.35 million -9.7%5.1%2.1 $13.11
11/15/20222,900,000 shares $38.54 million +7.8%5.6%2.6 $13.29
10/31/20222,690,000 shares $30.13 million -11.2%6.2%2.5 $11.20
10/15/20223,030,000 shares $27.85 million +6.3%7.0%3.2 $9.19
9/30/20222,850,000 shares $15.90 million +7.1%6.5%3.4 $5.58
9/15/20222,660,000 shares $13.51 million +56.5%6.7%7.8 $5.08
8/31/20221,700,000 shares $8.76 million +9.0%4.3%5 $5.15
8/15/20221,560,000 shares $8.05 million -4.9%3.8%4.6 $5.16
7/31/20221,640,000 shares $6.76 million -9.9%4.0%5.2 $4.12
7/15/20221,820,000 shares $7.90 million +1.1%4.4%5.4 $4.34
6/30/20221,800,000 shares $7.02 million -13.0%4.4%4.9 $3.90
6/15/20222,070,000 shares $7.14 million -10.4%5.0%5 $3.45
5/31/20222,310,000 shares $9.79 million +0.9%5.6%4.5 $4.24
5/15/20222,290,000 shares $9.25 million -8.8%5.5%4.3 $4.04
4/30/20222,510,000 shares $11.57 million +3.3%6.1%4.3 $4.61
4/15/20222,430,000 shares $12.15 million +5.2%5.9%3.9 $5.00
3/31/20222,310,000 shares $12.73 million -17.5%5.6%3.3 $5.51
3/15/20222,800,000 shares $14.76 million -3.1%6.8%4.1 $5.27
2/28/20222,890,000 shares $16.13 million +8.2%7.1%4.2 $5.58
2/15/20222,670,000 shares $15.27 million +1.1%6.6%3.7 $5.72
1/31/20222,640,000 shares $18.45 million +2.7%6.5%3.7 $6.99
1/15/20222,570,000 shares $20.20 million +11.3%N/A0 $7.86
12/31/20212,310,000 shares $19.68 million -28.3%5.7%3.6 $8.52
12/15/20213,220,000 shares $25.34 million -5.6%8.0%5.4 $7.87
11/30/20213,410,000 shares $26.26 million +3.0%8.4%6.7 $7.70
11/15/20213,310,000 shares $27.08 million -10.8%8.2%6.1 $8.18
10/29/20213,710,000 shares $29.83 million +4.2%9.2%5.9 $8.04
10/15/20213,560,000 shares $31.04 million -1.9%8.8%3.6 $8.72
Critical AI announcement set to ignite AI 2.0 (Ad)

I just put together an urgent new presentation that you need to see right away. In short: I believe we are mere days away from a critical announcement from a key tech leader… One that will officially ignite “AI 2.0” – and potentially send a whole new class of stocks soaring.

Click to find out what Nvidia’s CEO might reveal… and how Sykes is preparing to ride the wave.
9/30/20213,630,000 shares $31.54 million -15.2%9.0%3.5 $8.69
9/15/20214,280,000 shares $36.51 million -5.5%10.6%4.1 $8.53
8/31/20214,530,000 shares $39.23 million -11.5%11.2%4.2 $8.66
8/13/20215,120,000 shares $40.35 million +9.6%18.5%3.4 $7.88
7/30/20214,670,000 shares $48.85 million +2.2%20.5%3.2 $10.46
7/15/20214,570,000 shares $46.11 million -19.8%11.5%4 $10.09
6/30/20215,700,000 shares $60.25 million +6.0%14.3%5.2 $10.57
6/15/20215,380,000 shares $57.89 million -2.9%13.5%4.8 $10.76
5/28/20215,540,000 shares $83.99 million -13.7%13.9%4.8 $15.16
5/14/20216,420,000 shares $93.80 million +11.7%16.2%5.9 $14.61
4/30/20215,750,000 shares $93.73 million No Change14.2%4.3 $16.30
4/15/20215,750,000 shares $91.51 million -10.9%14.2%3.7 $15.92
3/31/20216,450,000 shares $96.75 million +41.1%15.9%4.1 $15.00
3/15/20214,570,000 shares $77.64 million +20.3%11.1%2.9 $16.99
2/26/20213,800,000 shares $60.57 million +12.4%9.2%2.7 $15.94
2/12/20213,380,000 shares $79.40 million +34.7%8.2%3.3 $23.49
1/29/20212,510,000 shares $98.44 million -1.6%6.2%3.3 $39.22
1/15/20212,550,000 shares $113.50 million -7.3%6.3%6.1 $44.51
12/31/20202,750,000 shares $135.66 million +118.3%6.8%6.7 $49.33
12/15/20201,260,000 shares $61.66 million -8.7%3.1%3 $48.94
11/30/20201,380,000 shares $68.77 million -28.1%3.4%3.2 $49.83
11/15/20201,920,000 shares $97.29 million -18.3%4.8%3.7 $50.67
10/30/20202,350,000 shares $100.93 million -7.1%7.7%4.4 $42.95
10/15/20202,530,000 shares $105.70 million +6.8%6.9%5 $41.78
9/30/20202,370,000 shares $83.40 million +52.9%6.4%5 $35.19
9/15/20201,550,000 shares $59.95 million +31.4%4.5%3 $38.68
8/31/20201,180,000 shares $40.07 million +26.9%3.5%2.2 $33.96
8/14/2020929,700 shares $25.40 million -13.9%2.7%2 $27.32
7/31/20201,080,000 shares $24.42 million -8.5%3.1%2.5 $22.61

IMVT Short Interest - Frequently Asked Questions

What is Immunovant's current short interest?

Short interest is the volume of Immunovant shares that have been sold short but have not yet been closed out or covered. As of June 30th, traders have sold 20,440,000 shares of IMVT short. 29.79% of Immunovant's shares are currently sold short. Learn More on Immunovant's current short interest.

What is a good short interest ratio for Immunovant?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IMVT shares currently have a short interest ratio of 15.0. Learn More on Immunovant's short interest ratio.

Which institutional investors are shorting Immunovant?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Immunovant: Jane Street Group LLC, Caption Management LLC, and HAP Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Immunovant?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 29.79% of Immunovant's floating shares are currently sold short.

Is Immunovant's short interest increasing or decreasing?

Immunovant saw a increase in short interest in the month of June. As of June 30th, there was short interest totaling 20,440,000 shares, an increase of 2.6% from the previous total of 19,920,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Immunovant's float size?

Immunovant currently has issued a total of 171,070,000 shares. Some of Immunovant's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Immunovant currently has a public float of 68,620,000 shares.

How does Immunovant's short interest compare to its competitors?

29.79% of Immunovant's shares are currently sold short. Here is how the short interest of companies compare to Immunovant: Soleno Therapeutics, Inc. (12.81%), Moderna, Inc. (19.15%), Dr. Reddy's Laboratories Ltd (1.34%), Viatris Inc. (3.51%), Qiagen N.V. (2.51%), Ascendis Pharma A/S (6.16%), BridgeBio Pharma, Inc. (14.05%), Verona Pharma PLC American Depositary Share (0.60%), Blueprint Medicines Corporation (5.95%), Roivant Sciences Ltd. (10.24%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($72.10 billion), Invesco QQQ ($26.89 billion), iShares Russell 2000 ETF ($19.61 billion), MicroStrategy Incorporated ($9.52 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), WD-40 Company ($7.66 billion), Technology Select Sector SPDR Fund ($6.10 billion), Invesco S&P 500 Equal Weight ETF ($5.80 billion), Invesco S&P 500 Top 50 ETF ($5.53 billion), and Vanguard Large-Cap ETF ($5.35 billion). View all of the most shorted stocks.

What does it mean to sell short Immunovant stock?

Short selling IMVT is an investing strategy that aims to generate trading profit from Immunovant as its price is falling. IMVT shares are trading down $0.22 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Immunovant?

A short squeeze for Immunovant occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of IMVT, which in turn drives the price of the stock up even further.

How often is Immunovant's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IMVT, twice per month. The most recent reporting period available is June, 30 2025.




This page (NASDAQ:IMVT) was last updated on 7/24/2025 by MarketBeat.com Staff
From Our Partners